Skip to search formSkip to main contentSkip to account menu

preclamol

Known as: 3-PPP, Phenol, 3-(1-propyl-3-piperidinyl)-, n-N-propyl-3-(3-hydroxyphenyl)piperidine 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Antiparkinson AgentsDopamine AgonistsPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum
The enantiomers of 3-PPP or haloperidol were injected in various doses to rats 1 hour after the established dopamine receptor… 
2005
2005
In vitro effect of the racemic mixture and the (−)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor
The racemic mixture and the (−)enantiomer of the putative dopamine autoreceptor agonist 3-PPP were investigatedin vitro using… 
2005
2005
A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine…
In naive mice the selective dopamine (DA) autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine) produced a… 
2005
2005
Suppression of neuroleptic-induced persistent abnormal movements in Cebus apella monkeys by enantiomers of 3-PPP
Effects of the enantiomers of the dopamine (DA) autoreceptor agonist 3-PPP (0.5–8.0 mg/kg body weight, i.m.) were studied in… 
2004
2004
The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat
The effects of the enantiomers of 3-PPP on the maintenance of conditioned avoidance responding (CAR) were studied. The weak… 
1987
1987
Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).
Eight indolizidine and quinolizidine derivatives of 3-PPP were synthesized and tested for possible dopamine (DA) autoreceptor… 
1987
1987
Antagonist effects of the enantiomers of 3-PPP towards alpha 1-adrenoceptors coupled to inositol phospholipid breakdown in the rat cerebral cortex.
The effects of the two enantiomers of 3-PPP upon alpha 1-adrenergic and muscarinic receptors coupled to the inositol phospholipid… 
1986
1986
Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics.
This study emphasizes the importance of the metabolic conversion of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine… 
1985
1985
Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine).
In an attempt to enhance the potency of the dopamine autoreceptor agonist 3-PPP, racemic cis-3-(3-hydroxyphenyl)-5… 
1982
1982
A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)